Header Logo

Connection

Hua Chen to Factor Xa Inhibitors

This is a "connection" page, showing publications Hua Chen has written about Factor Xa Inhibitors.
Connection Strength

0.238
  1. Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States. Expert Rev Pharmacoecon Outcomes Res. 2025 Jan; 25(1):63-70.
    View in: PubMed
    Score: 0.238
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.